Recent advances in the understanding of the role of synaptic proteins in Alzheimer's Disease and other neurodegenerative disorders.

Synaptic damage is an early pathological event common to many neurodegenerative disorders such as Alzheimer's disease (AD) and is the best correlate to the cognitive impairment. Several molecules involved in AD and in other neurodegenerative disorders play an important role in synaptic function and when misfolded aggregate and form amyloid fibrils. Synaptic proteins with an amyloid domain include amyloid beta-protein precursor, prion protein, huntingtin, ataxin-1 and alpha-synuclein. Two of the possible mechanisms by which alterations in synaptic proteins lead to synapse damage are: 1) misfolded or aggregated synaptic molecules have lost their normal function and/or 2) they have gained a toxic capacity. Recent studies support the possibility that while oligomers are toxic, polymers might be inactive. The mechanisms by which oligomers trigger synapse loss could be related to their ability to triggers stress signals once they enter the nucleus and/or accumulate at the endoplasmic reticulum.

[1]  E. Masliah,et al.  Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease , 2001, Neurology.

[2]  K. Prasad,et al.  Overexpression of human α-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells , 2000, Brain Research.

[3]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[4]  P. Silver,et al.  Polyglutamine Expansions Proteolysis, Chaperones, and the Dangers of Promiscuity , 2000, Neuron.

[5]  W. Bender,et al.  A Drosophila model of Parkinson's disease , 2000, Nature.

[6]  L. Mucke,et al.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. , 2000, Science.

[7]  E. Masliah,et al.  Role of Cytochrome c as a Stimulator of α-Synuclein Aggregation in Lewy Body Disease* , 1999, The Journal of Biological Chemistry.

[8]  L. Lue,et al.  Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .

[9]  H. Zoghbi,et al.  Progress in pathogenesis studies of spinocerebellar ataxia type 1. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[10]  L. Mucke,et al.  Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Citron,et al.  Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation* , 1999, The Journal of Biological Chemistry.

[12]  E. Masliah,et al.  Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro , 1999 .

[13]  M. Mattson,et al.  The Endoplasmic Reticulum Stress-Responsive Protein GRP78 Protects Neurons Against Excitotoxicity and Apoptosis: Suppression of Oxidative Stress and Stabilization of Calcium Homeostasis , 1999, Experimental Neurology.

[14]  B. Wieringa,et al.  Expanding complexity in myotonic dystrophy , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[15]  Makoto Hashimoto,et al.  Human recombinant NACP/α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease , 1998, Brain Research.

[16]  D. Dormont,et al.  Search for a Nuclear Localization Signal in the Prion Protein , 1998, Molecular and Cellular Neuroscience.

[17]  R. Doms,et al.  Detection of a Novel Intraneuronal Pool of Insoluble Amyloid β Protein that Accumulates with Time in Culture , 1998, The Journal of cell biology.

[18]  H. Vinters,et al.  Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. , 1998, The American journal of pathology.

[19]  W. Honer,et al.  Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. , 1998, The American journal of pathology.

[20]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[21]  Hitoshi Takahashi,et al.  NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease , 1997, Neuroscience Letters.

[22]  P Trouillas,et al.  Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. , 1997, Human molecular genetics.

[23]  B. Hyman,et al.  Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse , 1997, The Journal of Neuroscience.

[24]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[25]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[26]  D. Price,et al.  Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm , 1997, Nature.

[27]  S. Prusiner,et al.  Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity , 1996, Science.

[28]  R. Neve,et al.  Age-Dependent Neuronal and Synaptic Degeneration in Mice Transgenic for the C Terminus of the Amyloid Precursor Protein , 1996, The Journal of Neuroscience.

[29]  L. Mucke,et al.  Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein and Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[30]  V. Blanchard,et al.  Immunohistochemical analysis of presenilin‐1 expression in the mouse brain , 1996, FEBS letters.

[31]  P S Harper,et al.  Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human, mouse and rat brain. , 1996, Human molecular genetics.

[32]  J. Poirier,et al.  Apolipoprotein E, synaptic plasticity and Alzheimer's disease. , 1995, Annals of medicine.

[33]  David F. Clayton,et al.  Characterization of a novel protein regulated during the critical period for song learning in the zebra finch , 1995, Neuron.

[34]  M. Somerville,et al.  Characterization of myotonic dystrophy kinase (DMK) protein in human and rodent muscle and central nervous tissue. , 1995, Human molecular genetics.

[35]  E. Hirsch,et al.  Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form , 1995, Nature Genetics.

[36]  P. Coleman,et al.  Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease , 1995, Neurobiology of Aging.

[37]  L. Mucke,et al.  Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein , 1995, The Journal of experimental medicine.

[38]  D. Price,et al.  Role of the β‐amyloid protein in Alzheimer's disease , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[40]  Akihiko Iwai,et al.  The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.

[41]  D. Clair,et al.  Synuclein proteins and Alzheimer's disease , 1994, Trends in Neurosciences.

[42]  L. Mucke,et al.  Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice , 1994, Brain Research.

[43]  D. Price,et al.  Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. , 1994, The American journal of pathology.

[44]  M. Villanova,et al.  Apolipoprotein E expression at neuromuscular junctions in mouse, rat and human skeletal muscle , 1994, FEBS letters.

[45]  E. Masliah,et al.  Reduction of Neurological Damage by a Peptide Segment of the Amyloid β/A4 Protein Precursor in a Rabbit Spinal Cord Ischemia Model , 1994, Experimental Neurology.

[46]  E. Masliah,et al.  Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Mattson,et al.  Secreted Forms of β‐Amyloid Precursor Protein Protect Against Ischemic Brain Injury , 1994 .

[48]  M. Palmer,et al.  Prion protein is necessary for normal synaptic function , 1994, Nature.

[49]  Michel Goedert,et al.  Identification of two distinct synucleins from human brain , 1994, FEBS letters.

[50]  D. Mann.  Pathological correlates of dementia in Alzheimer's disease , 1994, Neurobiology of Aging.

[51]  E. Masliah,et al.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[52]  K. Jellinger,et al.  Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients , 1993, Neuroscience Letters.

[53]  S. Nakajo,et al.  A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation. , 1993, European journal of biochemistry.

[54]  M. Mattson,et al.  Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein , 1993, Neuron.

[55]  W. Engel,et al.  Strong immunoreactivity of β-amyloid precursor protein, including the β-amyloid protein sequence, at human neuromuscular junctions , 1992, Neuroscience Letters.

[56]  K. Titani,et al.  Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain. , 1992, The Journal of biological chemistry.

[57]  K. Doh-ura,et al.  The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system. , 1992, The American journal of pathology.

[58]  R. Shin,et al.  Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. , 1992, The American journal of pathology.

[59]  E. Masliah,et al.  Localization of amyloid precursor protein in GAP43-immunoreactive aberrant sprouting neurites in Alzheimer's disease , 1992, Brain Research.

[60]  Walter Schubert,et al.  Localization of Alzheimer βA4 amyloid precursor protein at central and peripheral synaptic sites , 1991, Brain Research.

[61]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[62]  R. Scheller,et al.  The rat brain synucleins; family of proteins transiently associated with neuronal membrane. , 1991, Brain research. Molecular brain research.

[63]  Entorhinal lesions in dementia *H. Braak. Anatomical Department, J.W. Goethe University, 6000 Frankfurt 70. Fed. Rep. Germany. , 1990, Neurobiology of Aging.

[64]  R. Scheller,et al.  Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[65]  G. V. Van Hoesen,et al.  Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease , 1987, Annals of neurology.

[66]  Y. Kokubo,et al.  [Apolipoprotein E]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[67]  E. Masliah,et al.  alpha-synuclein promotes mitochondrial deficit and oxidative stress. , 2000, The American journal of pathology.

[68]  L. Lue,et al.  Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. , 1999, The American journal of pathology.

[69]  D. Salmon,et al.  Neuropathological Correlates of Dementia in Alzheimer’s Disease , 1999 .

[70]  E. Masliah,et al.  Molecular Mechanisms of Synaptic Disconnection in Alzheimer’s Disease , 1997 .

[71]  E. Masliah,et al.  Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. , 1996, The American journal of pathology.

[72]  岩井晃彦.  新規アルツハイマー病アミロイド構成成分non-Aβcomponent of Alzheimer′s disease amyloid(NAC)の研究 -その脳内局在とアミロイド形成への関与 , 1996 .

[73]  M. Adams,et al.  The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families , 1995, Nature Genetics.

[74]  M. Royston,et al.  Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study. , 1993, Neuroreport.